Abstract
Bacteria have been one of the world’s most dangerous and deadliest pathogens for mankind, nowadays giving rise to significant public health concerns. Given the prevalence of these microbial pathogens and their increasing resistance to existing antibiotics, there is a pressing need for new antibacterial drugs. However, development of a successful drug is a complex, costly, and time-consuming process. Quantitative Structure-Activity Relationships (QSAR)-based approaches are valuable tools for shortening the time of lead compound identification but also for focusing and limiting time-costly synthetic activities and in vitro/vivo evaluations. QSAR-based approaches, supported by powerful statistical techniques such as artificial neural networks (ANNs), have evolved to the point of integrating dissimilar types of chemical and biological data. This chapter reports an overview of the current research and potential applications of QSAR modeling tools toward the rational design of more efficient antibacterial agents. Particular emphasis is given to the setup of multitasking models along with ANNs aimed at jointly predicting different antibacterial activities and safety profiles of drugs/chemicals under diverse experimental conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grayson ML, Crowe SM et al (eds) (2010) Kucers’ the use of antibiotics. A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, 6th edn. CRC Press, Taylor & Francis Group, LLC, Boca Raton, FL
Shatalin K, Shatalina E et al (2011) H2S: a universal defense against antibiotics in bacteria. Science 334:986–990
Cordero OX, Wildschutte H et al (2012) Ecological populations of bacteria act as socially cohesive units of antibiotic production and resistance. Science 337:1228–1231
Rossolini GM, Mantengoli E (2008) Antimicrobial resistance in Europe and its potential impact on empirical therapy. Clin Microbiol Infect 14(Suppl 6):2–8
Gonzales R, Corbett KK et al (2008) Drug resistant infections in poor countries: a shrinking window of opportunity. BMJ 336:948–949
Lautenbach E, Abrutyn E (2009) Healthcare-acquired bacterial infections. In: Brachman PS, Abrutyn E (eds) Bacterial infections of humans: epidemiology and control, 4th edn. Springer Science + Business Media, LLC, New York, NY, pp 543–575
Rigottier-Gois L, Alberti A et al (2011) Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors. PLoS One 6:e29023
Tenover FC, McGowan JE Jr (2009) The epidemiology of bacterial resistance to antimicrobial agents. In: Brachman PS, Abrutyn E (eds) Bacterial infections of humans: epidemiology and control, 4th edn. Springer Science + Business Media, LLC, New York, NY, pp 91–104
Feuerriegel S, Oberhauser B et al (2012) Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. BMC Microbiol 12:90
Lienhardt C, Glaziou P et al (2012) Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 10:407–416
Hann MM, Oprea TI (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8:255–263
Lazo JS, Wipf P (2000) Combinatorial chemistry and contemporary pharmacology. J Pharmacol Exp Ther 293:705–709
Bleicher KH, Bohm HJ et al (2003) Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2:369–378
Hansch C, Leo A (1995) Exploring QSAR: fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DC
Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303:1813–1818
Oprea T (2005) Chemoinformatics in drug discovery. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Brown N, Lewis RA (2006) Exploiting QSAR methods in lead optimization. Curr Opin Drug Discov Devel 9:419–424
Borchardt RT, Kerns EH et al (eds) (2006) Optimizing the “drug-like” properties of leads in drug discovery. Springer Science + Business Media, LLC, New York, NY
Croes S, Koop AH et al (2012) Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Eur J Pharm Sci 45:90–100
Hau J, Schapiro SJ (2011) Handbook of laboratory animal science: essential principles and practices. CRC Press, Taylor & Francis Group, LLC, Boca Raton, FL
Vina D, Uriarte E et al (2009) Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol Pharm 6:825–835
Prado-Prado FJ, Garcia-Mera X et al (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem 18:2225–2231
Garcia I, Fall Y et al (2011) First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines. Mol Divers 15:561–567
Speck-Planche A, Kleandrova VV et al (2012) Fragment-based approach for the in silico discovery of multi-target insecticides. Chemometr Intell Lab Syst 111:39–45
Speck-Planche A, Kleandrova VV et al (2012) In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis. Comb Chem High Throughput Screen 15:666–673
Speck-Planche A, Kleandrova VV et al (2012) Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of anti-breast cancer agents. Eur J Pharm Sci 47:273–279
Speck Planche A, Cordeiro MNDS (2013) In Chemoinformatics in drug design. Artificial neural networks for simultaneous prediction of anti-enterococci activities and toxicological profiles. Proceedings of the 5th International joint conference on computational intelligence, NCTA-International conference on neural computation theory and applications, Vilamoura, Algarve, Portugal, 20–22 Sept, pp 458–465
Luan F, Cordeiro MNDS et al (2013) TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg Med Chem 21:1870–1879
Tenorio-Borroto E, Penuelas Rivas CG et al (2012) ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen. Bioorg Med Chem 20:6181–6194
Speck-Planche A, Kleandrova VV et al (2013) New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Eur J Pharm Sci 48:812–818
Speck-Planche A, Kleandrova VV et al (2013) Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals. Bioorg Med Chem 21:2727–2732
Speck-Planche A, Cordeiro MNDS (2013) Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry. Curr Top Med Chem 13:1656–1665
van de Waterbeemd H (1995) Chemometrics methods in molecular design. VCH Publishers, Weinheim
Gaulton A, Bellis LJ et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–D1107
Knox C, Law V et al (2011) DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 39:D1035–D1041
Mok NY, Brenk R (2011) Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. J Chem Inf Model 51:2449–2454
Todeschini R, Consonni V (2000) Handbook of molecular descriptors. WILEY-VCH Verlag GmbH, Weinheim
Kubinyi H (1993) QSAR: Hansch analysis and related approaches. VCH Publishers, Weinheim
Kubinyi H, Folkers G et al (eds) (2002) 3D QSAR in drug design: recent advances. Kluwer Academic Publishers, New York
Klein CD, Hopfinger AJ (1998) Pharmacological activity and membrane interactions of antiarrhythmics: 4D-QSAR/QSPR analysis. Pharm Res 15:303–311
Vedani A, Dobler M (2002) 5D-QSAR: the key for simulating induced fit? J Med Chem 45:2139–2149
Vedani A, Dobler M et al (2005) Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor. J Med Chem 48:3700–3703
Carloni P, Alber F (eds) (2003) Quantum medicinal chemistry. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Li P, Yin J et al (2013) Synthesis, antibacterial activities, and 3D-QSAR of sulfone derivatives containing 1,3,4-oxadiazole moiety. Chem Biol Drug Des 82:546–556
Lu X, Lv M et al (2012) Pharmacophore and molecular docking guided 3D-QSAR study of bacterial enoyl-ACP reductase (FabI) inhibitors. Int J Mol Sci 13:6620–6638
Uddin R, Lodhi MU et al (2012) Combined pharmacophore and 3D-QSAR study on a series of Staphylococcus aureus Sortase A inhibitors. Chem Biol Drug Des 80:300–314
Bhonsle JB, Venugopal D et al (2007) Application of 3D-QSAR for identification of descriptors defining bioactivity of antimicrobial peptides. J Med Chem 50:6545–6553
Bucinski A et al (2004) Artificial neural networks for prediction of antibacterial activity in series of imidazole derivatives. Comb Chem High Throughput Screen 7:327–336
Todeschini R, Consonni V (2009) Molecular descriptors for chemoinformatics. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Estrada E, Matamala AR (2007) Generalized topological indices. Modeling gas-phase rate coefficients of atmospheric relevance. J Chem Inf Model 47:794–804
Estrada E, Uriarte E et al (2000) A novel approach for the virtual screening and rational design of anticancer compounds. J Med Chem 43:1975–1985
Roy K, Ghosh G (2004) QSTR with extended topochemical atom indices. 2. Fish toxicity of substituted benzenes. J Chem Inf Comput Sci 44:559–567
Roy K, Ghosh G (2008) QSTR with extended topochemical atom indices. 10. Modeling of toxicity of organic chemicals to humans using different chemometric tools. Chem Biol Drug Des 72:383–394
Castillo-Garit JA, Vega MC et al (2011) Ligand-based discovery of novel trypanosomicidal drug-like compounds: in silico identification and experimental support. Eur J Med Chem 46:3324–3330
Casañola-Martin GM, Marrero-Ponce Y et al (2010) Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation. Chem Biol Drug Des 76:538–545
Barigye SJ, Marrero-Ponce Y et al (2013) Event-based criteria in GT-STAF information indices: theory, exploratory diversity analysis and QSPR applications. SAR QSAR Environ Res 24:3–34
Barigye SJ, Marrero-Ponce Y et al (2013) Relations frequency hypermatrices in mutual, conditional and joint entropy-based information indices. J Comput Chem 34:259–274
Vazquez-Prieto S, Gonzalez-Diaz H et al (2013) A QSPR-like model for multilocus genotype networks of Fasciola hepatica in Northwest Spain. J Theor Biol 343C:16–24
Alonso N, Caamano O et al (2013) Model for high-throughput screening of multi-target drugs in chemical neurosciences; synthesis, assay and theoretic study of rasagiline carbamates. ACS Chem Neurosci 4:1393–1403
Estrada E, Molina E et al (2001) Can 3D structural parameters be predicted from 2D (topological) molecular descriptors? J Chem Inf Comput Sci 41:1015–1021
Estrada E (2002) Physicochemical interpretation of molecular connectivity indices. J Phys Chem A 106:9085–9091
Molina E, Diaz HG et al (2004) Designing antibacterial compounds through a topological substructural approach. J Chem Inf Comput Sci 44:515–521
Gonzalez-Diaz H, Torres-Gomez LA et al (2005) Markovian chemicals “in silico” design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials. J Mol Model 11:116–123
Marrero-Ponce Y, Marrero RM et al (2006) Non-stochastic and stochastic linear indices of the molecular pseudograph’s atom-adjacency matrix: a novel approach for computational in silico screening and “rational” selection of new lead antibacterial agents. J Mol Model 12:255–271
Marrero-Ponce Y, Medina-Marrero R et al (2005) Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity. Bioorg Med Chem 13:2881–2899
Speck-Planche A, Scotti MT et al (2009) Design of novel antituberculosis compounds using graph-theoretical and substructural approaches. Mol Divers 13:445–458
Estrada E (1996) Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications for the prediction of physical properties of alkanes. J Chem Inf Comput Sci 36:844–849
Estrada E (1997) Spectral moments of the edge adjacency matrix in molecular graphs. 2. Molecules containing heteroatoms and QSAR applications. J Chem Inf Comput Sci 37:320–328
Estrada E (1998) Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles. J Chem Inf Comput Sci 38:23–27
Estrada E, Gutiérrez Y (2002–2004) MODESLAB. v1.5, Santiago de Compostela
Yap CW (2011) PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32:1466–1474
Todeschini R, Lasagni M et al (1994) New molecular descriptors for 2D and 3D structures. Theory. J Chemometr 8:263–272
Hill T, Lewicki P (2006) STATISTICS methods and applications. A comprehensive reference for science, industry and data mining. StatSoft, Tulsa
Suzuki K (ed) (2011) Artificial neural networks: methodological advances and biomedical applications. InTech, Rijeka
Sabet R, Fassihi A et al (2012) Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach. J Comput Aided Mol Des 26:349–361
Garcia-Domenech R, de Julian-Ortiz JV (1998) Antimicrobial activity characterization in a heterogeneous group of compounds. J Chem Inf Comput Sci 38:445–449
Lata S, Sharma BK et al (2007) Analysis and prediction of antibacterial peptides. BMC Bioinformatics 8:263
Hall M, Frank E et al (2009) The WEKA data mining software: an update. SIGKDD Explor 11:10–18
Hall M, Frank E et al (1999–2013) WEKA. Waikato Environment for Knowledge Analysis. v3.6.9, Hamilton
Witten IH, Frank E et al (2011) Data mining: practical machine learning tools and techniques. Morgan Kaufmann Publishers, Elsevier, Amsterdam
StatSoft (2001) STATISTICA 6.0. Data analysis software system
González-Díaz H, Pérez-Bello A et al (2007) Chemometrics for QSAR with low sequence homology: Mycobacterial promoter sequences recognition with 2D-RNA entropies. Chemometr Intell Lab Syst 85:20–26
Hanczar B, Hua J et al (2010) Small-sample precision of ROC-related estimates. Bioinformatics 26:822–830
Sader HS, Biedenbach DJ et al (2012) Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 56:1619–1623
Acknowledgments
A. Speck-Planche acknowledges the Portuguese Fundação para a Ciência e a Tecnologia (FCT) and the European Social Fund for financial support (grant SFRH/BD/77690/2011). This work has been further supported by FCT through grant N° Pest-C/EQB/LA0006/2011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Speck-Planche, A., Cordeiro, M.N.D.S. (2015). A General ANN-Based Multitasking Model for the Discovery of Potent and Safer Antibacterial Agents. In: Cartwright, H. (eds) Artificial Neural Networks. Methods in Molecular Biology, vol 1260. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2239-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2239-0_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2238-3
Online ISBN: 978-1-4939-2239-0
eBook Packages: Springer Protocols